Niemann-Pick C Disease Gene Mutations and Age-Related Neurodegenerative Disorders

2013 | journal article. A publication with affiliation to the University of Göttingen.

Jump to: Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​Niemann-Pick C Disease Gene Mutations and Age-Related Neurodegenerative Disorders​
Zech, M.; Nuebling, G.; Castrop, F.; Jochim, A.; Schulte, E. C.; Mollenhauer, B. & Lichtner, P. et al.​ (2013) 
PLoS ONE8(12) art. e82879​.​ DOI: https://doi.org/10.1371/journal.pone.0082879 

Documents & Media

journal.pone.0082879.pdf169.48 kBAdobe PDF

License

Published Version

Attribution 2.5 CC BY 2.5

Details

Authors
Zech, Michael; Nuebling, Georg; Castrop, Florian; Jochim, Angela; Schulte, Eva C.; Mollenhauer, Brit; Lichtner, Peter; Peters, Annette; Gieger, Christian; Marquardt, Thorsten; Vanier, Marie T.; Latour, Philippe; Kluenemann, Hans H.; Trenkwalder, Claudia; Diehlschmid, Janine; Perneczky, Robert; Meitinger, Thomas; Oexle, Konrad; Haslinger, Bernhard; Lorenzl, Stefan; Winkelmann, Juliane
Abstract
Niemann-Pick type C (NPC) disease is a rare autosomal-recessively inherited lysosomal storage disorder caused by mutations in NPC1 (95%) or NPC2. Given the highly variable phenotype, diagnosis is challenging and particularly late-onset forms with predominantly neuropsychiatric presentations are likely underdiagnosed. Pathophysiologically, genetic alterations compromising the endosomal/lysosomal system are linked with age-related neurodegenerative disorders. We sought to examine a possible association of rare sequence variants in NPC1 and NPC2 with Parkinson's disease (PD), frontotemporal lobar degeneration (FTLD) and progressive supranuclear palsy (PSP), and to genetically determine the proportion of potentially misdiagnosed NPC patients in these neurodegenerative conditions. By means of high-resolution melting, we screened the coding regions of NPC1 and NPC2 for rare genetic variation in a homogenous German sample of patients clinically diagnosed with PD (n = 563), FTLD (n = 133) and PSP (n = 94), and 846 population-based controls. The frequencies of rare sequence variants in NPC1/2 did not differ significantly between patients and controls. Disease-associated NPC1/2 mutations were found in six PD patients (1.1%) and seven control subjects (0.8%), but not in FTLD or PSP. All rare variation was detected in the heterozygous state and no compound heterozygotes were observed. Our data do not support the hypothesis that rare NPC1/2 variants confer susceptibility for PD, FTLD, or PSP in the German population. Misdiagnosed NPC patients were not present in our samples. However, further assessment of NPC disease genes in age-related neurodegeneration is warranted.
Issue Date
2013
Status
published
Publisher
Public Library Science
Journal
PLoS ONE 
ISSN
1932-6203

Reference

Citations


Social Media